Description

LGD-4033 (Ligandrol) — Research Grade SARM

By Combat Research® | Best Place for SARMs & Peptides (RUO)

Meta Title (SEO)

Injectable LGD-4033 Ligandrol | Research Grade SARM | Combat Research®

Meta Description (SEO)

Injectable LGD-4033 (Ligandrol) for laboratory research only. Combat Research® is the best place for SARMs and peptides—research-grade quality with FDA-safe RUO labeling.

Product Overview

Injectable LGD-4033 (Ligandrol) is a non-steroidal Selective Androgen Receptor Modulator (SARM) supplied by Combat Research® strictly for research use only (RUO). LGD-4033 is widely referenced in androgen receptor (AR) binding, gene transcription, and endocrinology research due to its high affinity and selectivity for the androgen receptor in controlled laboratory settings.

At Combat Research, we provide clearly labeled, research-grade SARMs and peptides with compliance-focused presentation—making us the best place for SARMs and peptides for qualified researchers.

Why Combat Research®

• Research-only positioning with FDA/FTC-safe RUO language

• Professional labeling and documentation standards

• Trusted supplier of SARMs, peptides, and research chemicals

• No therapeutic, performance, or consumption claims

Chemical & Technical Specifications

• Compound Name: LGD-4033 (Ligandrol)

• Compound Class: Selective Androgen Receptor Modulator (SARM)

• CAS Number: 1165910-22-4

• Molecular Formula: C14H12ClN5O

• Molecular Weight: 305.73 g/mol

• Form: Injectable research solution

• Intended Use: Laboratory research only

Research Description (Non-Clinical)

Scientific literature characterizes LGD-4033 as a potent, selective androgen receptor ligand investigated in preclinical and early-phase clinical research contexts to understand:

• Androgen receptor binding and selectivity

• AR-mediated gene transcription pathways

• Skeletal muscle and bone signaling models (non-clinical)

• Endocrine system and hormonal regulation research

• Comparative SARM pharmacology vs. steroidal androgens

All references are provided for academic background only and do not imply clinical, therapeutic, or performance use.

PubMed / Scientific References

• PMID: 24141057 — First-in-human study describing LGD-4033 pharmacology and AR selectivity

• PMID: 25283808 — Review of SARMs including LGD-4033 and androgen receptor signaling

• PMID: 28644171 — Androgen receptor modulation and tissue selectivity overview

(All cited literature is referenced for research context only.)

Common Research Applications

• Androgen receptor signaling assays

• Nuclear receptor transcription studies

• Endocrinology and hormonal pathway models

• Muscle and bone metabolism research (preclinical)

• Structure–activity relationship (SAR) studies of SARMs

Primary Keywords:
Injectable LGD-4033, LGD-4033 injectable, LGD-4033 Ligandrol, LGD-4033 SARM

Secondary Keywords:
Research grade LGD-4033, LGD-4033 research chemical, injectable SARM research, androgen receptor modulator, non-steroidal SARM

Brand & Authority Keywords:
Combat Research LGD-4033, Combat Research SARMs, Combat Research peptides, best place for SARMs and peptides, research SARMs supplier

FDA-Safe Research Use Disclaimer

FOR RESEARCH USE ONLY (RUO).
Not for human consumption. Not for veterinary use. Not for diagnostic, therapeutic, or clinical use. This product is intended solely for laboratory research by qualified professionals in controlled research environments.

Statements regarding this product have not been evaluated by the U.S. Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.